BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28737095)

  • 1. Impact of Body Mass Index on Complications and Survival after Surgery for Esophageal and Gastro-Esophageal-Junction Cancer.
    Kruhlikava I; Kirkegård J; Mortensen FV; Kjær DW
    Scand J Surg; 2017 Dec; 106(4):305-310. PubMed ID: 28737095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Salem AI; Thau MR; Strom TJ; Abbott AM; Saeed N; Almhanna K; Hoffe SE; Shridhar R; Karl RC; Meredith KL
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27149640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone.
    Achiam MP; Jensen LB; Larsson H; Jensen LS; Larsen AC; Holm J; Svendsen LB
    Scand J Surg; 2016 Mar; 105(1):22-8. PubMed ID: 25794689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival.
    Blom RL; Lagarde SM; Klinkenbijl JH; Busch OR; van Berge Henegouwen MI
    Ann Surg Oncol; 2012 Mar; 19(3):766-71. PubMed ID: 21979112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extremes of body mass index and postoperative complications after esophagectomy.
    Wightman SC; Posner MC; Patti MG; Ganai S; Watson S; Prachand V; Ferguson MK
    Dis Esophagus; 2017 May; 30(5):1-6. PubMed ID: 28375438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients.
    Sunpaweravong S; Ruangsin S; Laohawiriyakamol S; Mahattanobon S; Geater A
    Asian J Surg; 2012 Jul; 35(3):104-9. PubMed ID: 22884266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
    Ti TK
    Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body mass index on surgical outcomes after esophagectomy for patients with esophageal squamous cell carcinoma.
    Hasegawa T; Kubo N; Ohira M; Sakurai K; Toyokawa T; Yamashita Y; Yamazoe S; Kimura K; Nagahara H; Amano R; Shibutani M; Tanaka H; Muguruma K; Ohtani H; Yashiro M; Maeda K; Hirakawa K
    J Gastrointest Surg; 2015 Feb; 19(2):226-33. PubMed ID: 25398407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
    Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
    Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction.
    Xia BT; Rosato EL; Chojnacki KA; Crawford AG; Weksler B; Berger AC
    World J Surg; 2013 Feb; 37(2):408-15. PubMed ID: 23052816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An elevated body mass index does not reduce survival after esophagectomy for cancer.
    Melis M; Weber JM; McLoughlin JM; Siegel EM; Hoffe S; Shridhar R; Turaga KK; Dittrick G; Dean EM; Karl RC; Meredith KL
    Ann Surg Oncol; 2011 Mar; 18(3):824-31. PubMed ID: 20865331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Body Mass Index Worsens Survival in Patients with Esophageal Squamous Cell Carcinoma after Esophagectomy.
    Duan XF; Tang P; Shang XB; Jiang HJ; Zhao Q; Yu ZT
    Dig Surg; 2017; 34(4):319-327. PubMed ID: 28099956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total thoracic esophagectomy for esophageal cancer.
    Anikin VA; McManus KG; Graham AN; McGuigan JA
    J Am Coll Surg; 1997 Dec; 185(6):525-9. PubMed ID: 9404874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy.
    Miao L; Chen H; Xiang J; Zhang Y
    J Cancer Res Clin Oncol; 2015 May; 141(5):941-50. PubMed ID: 25428458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013.
    Kjaer DW; Larsson H; Svendsen LB; Jensen LS
    Br J Surg; 2017 Sep; 104(10):1338-1345. PubMed ID: 28718940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.
    Rizk NP; Bach PB; Schrag D; Bains MS; Turnbull AD; Karpeh M; Brennan MF; Rusch VW
    J Am Coll Surg; 2004 Jan; 198(1):42-50. PubMed ID: 14698310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body mass index on postoperative complications and long-term survival in patients with esophageal squamous cell cancer.
    Kamachi K; Ozawa S; Hayashi T; Kazuno A; Ito E; Makuuchi H
    Dis Esophagus; 2016 Apr; 29(3):229-35. PubMed ID: 25789403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.